Ardent Health, Inc. earnings per share and revenue
On Mar 04, 2026, ARDT reported earnings of 0.32 USD per share (EPS) for Q4 25, missing the estimate of 0.34 USD, resulting in a -8.23% surprise. Revenue reached 1.61 billion, compared to an expected 1.66 billion, with a -3.53% difference. The market reacted with a -2.07% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 12 analysts forecast an EPS of 0.18 USD, with revenue projected to reach 1.61 billion USD, implying an decrease of -43.75% EPS, and increase of 0.36% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
The Oncology Institute, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.06
Surprise
+33.99%
The Beauty Health Company Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.06
Surprise
-14.29%
Sera Prognostics, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.16
Surprise
+17.44%
DocGo Inc. Common Stock
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.13
Actual
-$1.37
Surprise
-920.10%
HealthEquity, Inc
Report Date
Mar 17, 2026 For Q4 26
Estimate
$0.90
Actual
$0.95
Surprise
+4.51%
IceCure Medical Ltd. Ordinary Shares
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.07
Surprise
-52.51%
Lifeward Ltd. Ordinary Shares
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$1.10
Actual
-$3.60
Surprise
-226.80%
SeaStar Medical Holding Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.07
Actual
-$0.80
Surprise
+25.28%
Healthy Choice Wellness Corp.
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.05
Surprise
+1.96%
Aclarion, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$3.67
Actual
-$2.54
Surprise
+30.83%
FAQ
What were Ardent Health, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Ardent Health, Inc. reported EPS of $0.32, missing estimates by -8.23%, and revenue of $1.61B, -3.53% below expectations.
How did the market react to Ardent Health, Inc.'s Q4 2025 earnings?
The stock price moved down -2.07%, changed from $9.64 before the earnings release to $9.44 the day after.
When is Ardent Health, Inc. expected to report next?
The next earning report is scheduled for May 04, 2026.
What are the forecasts for Ardent Health, Inc.'s next earnings report?
Based on 12
analysts, Ardent Health, Inc. is expected to report EPS of $0.18 and revenue of $1.61B for Q1 2026.